Kevan R. Thompson

587 total citations
11 papers, 499 citations indexed

About

Kevan R. Thompson is a scholar working on Oncology, Organic Chemistry and Cancer Research. According to data from OpenAlex, Kevan R. Thompson has authored 11 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Organic Chemistry and 3 papers in Cancer Research. Recurrent topics in Kevan R. Thompson's work include Peptidase Inhibition and Analysis (3 papers), Synthesis of β-Lactam Compounds (3 papers) and Protease and Inhibitor Mechanisms (3 papers). Kevan R. Thompson is often cited by papers focused on Peptidase Inhibition and Analysis (3 papers), Synthesis of β-Lactam Compounds (3 papers) and Protease and Inhibitor Mechanisms (3 papers). Kevan R. Thompson collaborates with scholars based in United States. Kevan R. Thompson's co-authors include Paul E. Finke, Nelu Grinberg, Richard A. Thompson, David A. Conlon, Thomas P. O’Brien, Pascal H. Toma, G. Bicker, Binyamin Feibush, Alan L. Maycock and Bonnie M. Ashe and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Analytical Chemistry.

In The Last Decade

Kevan R. Thompson

11 papers receiving 475 citations

Peers

Countries citing papers authored by Kevan R. Thompson

Since Specialization

Citations

This map shows the geographic impact of Kevan R. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevan R. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevan R. Thompson more than expected).

Fields of papers citing papers by Kevan R. Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevan R. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevan R. Thompson. The network helps show where Kevan R. Thompson may publish in the future.

Co-authorship network of co-authors of Kevan R. Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of Kevan R. Thompson. A scholar is included among the top collaborators of Kevan R. Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevan R. Thompson. Kevan R. Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Mechanistic Aspects of Chiral Discrimination on an Amylose Tris(3,5-dimethylphenyl)carbamate 2002 ·PubMed ·Y. Bereznitski, Rosario LoBrutto, Narayan Variankaval, Richard A. Thompson, Kevan R. Thompson, Peter Sajonz, (unknown), (unknown), (unknown), Michel Journet, (unknown), Jean Wyvratt, Nelu Grinberg	21
2	Mechanistic Aspects of Chiral Discrimination on Modified Cellulose 1997 ·Analytical Chemistry ·Thomas P. O’Brien, (unknown), Richard A. Thompson, Kevan R. Thompson, Pascal H. Toma, David A. Conlon, Binyamin Feibush, (unknown), G. Bicker, Nelu Grinberg	188
3	Inhibition of human leukocyte elastase. 7. Inhibition by 6-substituted penicillin amides. 1993 ·Bioorganic & Medicinal Chemistry Letters ·Kevan R. Thompson, Paul E. Finke, Shrenik K. Shah, Bonnie M. Ashe, Mary Ellen Dahlgren, Pam S. Dellea, D. Fletcher, (unknown), Alan L. Maycock, James B. Doherty	7
4	Inhibition of human leukocyte elastase. 6. Inhibition by 6-substituted penicillin esters. 1993 ·Bioorganic & Medicinal Chemistry Letters ·Kevan R. Thompson, Paul E. Finke, Shrenik K. Shah, Bonnie M. Ashe, Mary Ellen Dahlgren, Alan L. Maycock, James B. Doherty	9
5	Chemical, biochemical, pharmacokinetic, and biological properties of L-680,833: a potent, orally active monocyclic beta-lactam inhibitor of human polymorphonuclear leukocyte elastase. 1993 ·Proceedings of the National Academy of Sciences ·James B. Doherty, S. K. Shah, Paul E. Finke, Conrad P. Dorn, (unknown), Jeffrey J. Hale, (unknown), Kevan R. Thompson, (unknown), Gilbert O. Chandler	29
6	The effect of N-acyl substituents on the stability of monocyclic β-lactam inhibitors of human leukocyte elastase 1992 ·Bioorganic & Medicinal Chemistry Letters ·William K. Hagmann, Kevan R. Thompson, Shrenik K. Shah, Paul E. Finke, Bonnie M. Ashe, (unknown), Alan L. Maycock, James B. Doherty	15
7	ChemInform Abstract: Inhibition of Human Leukocyte Elastase. Part 2. Inhibition by Substituted Cephalosporin Esters and Amides. 1991 ·ChemInform ·Paul E. Finke, Bonnie M. Ashe, Wilson B. Knight, Alan L. Maycock, Manuel A. Navia, Shrenik K. Shah, Kevan R. Thompson, (unknown), (unknown), M.D. Zimmerman, James B. Doherty	1
8	Prevention of human leukocyte elastase-mediated lung damage by 3-alkyl-4-azetidinones 1991 ·Bioorganic & Medicinal Chemistry Letters ·William K. Hagmann, Shrenik K. Shah, Conrad P. Dorn, Laura O’Grady, Jeffrey J. Hale, (unknown), Kevan R. Thompson, (unknown), (unknown), (unknown), Mary Ellen Dahlgren, Alan L. Maycock, Pam S. Dellea, (unknown), (unknown), Robert J. Bonney, Philip R. Davies, Daniel S. Fletcher, James B. Doherty	25
9	Inhibition of human leukocyte elastase. 2. Inhibition by substituted cephalosporin esters and amides 1990 ·Journal of Medicinal Chemistry ·(unknown), Bonnie M. Ashe, Wilson B. Knight, Alan L. Maycock, Manuel A. Navia, S. K. Shah, Kevan R. Thompson, (unknown), (unknown)	48
10	Preparation and Cyclization of Aryloxyacetaldehyde Acetals; A General Synthesis of 2,3-Unsubstituted Benzofurans 1989 ·Synthetic Communications ·Peter L. Barker, Paul E. Finke, Kevan R. Thompson	22
11	Cephalosporin antibiotics can be modified to inhibit human leukocyte elastase 1986 ·Nature ·James B. Doherty, Bonnie M. Ashe, Lawrence W. Argenbright, Peter L. Barker, Robert J. Bonney, Gilbert O. Chandler, Mary Ellen Dahlgren, Conrad P. Dorn, Paul E. Finke, Raymond A. Firestone, Daniel S. Fletcher, William K. Hagmann, Richard A. Mumford, Laura O’Grady, Alan L. Maycock, Judith M. Pisano, Shrenik K. Shah, Kevan R. Thompson, Morris Zimmerman	134

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact